- $15.4 million in fourth quarter 2011 net product sales, a 17% sequential increase over the third quarter of 2011.
- $50.5 million in full year 2011 net product sales, a 43% increase over 2010.
- $97.8 million in total cash, cash equivalents and investments and no debt as of December 31, 2011.
Allos Therapeutics, Inc. (NASDAQ: ALTH) today reported financial results for the fourth quarter and full year ended December 31, 2011. Financial Highlights: